Literature DB >> 16365175

Intensive surveillance after stage II or III colorectal cancer: is it worth it?

Richard M Goldberg.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16365175     DOI: 10.1200/JCO.2005.03.8323

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


× No keyword cloud information.
  5 in total

1.  Intensive or not surveillance of patients with colorectal cancer after curative resection.

Authors:  Gerardo Rosati
Journal:  World J Gastroenterol       Date:  2010-03-28       Impact factor: 5.742

Review 2.  Use of FDG-PET or PET/CT to detect recurrent colorectal cancer in patients with elevated CEA: a systematic review and meta-analysis.

Authors:  Yu-Yu Lu; Jin-Hua Chen; Chun-Ru Chien; William Tzu-Liang Chen; Shih-Chuan Tsai; Wan-Yu Lin; Chia-Hung Kao
Journal:  Int J Colorectal Dis       Date:  2013-02-14       Impact factor: 2.571

3.  Priming cancer cells for drug resistance: role of the fibroblast niche.

Authors:  Wei Bin Fang; Min Yao; Nikki Cheng
Journal:  Front Biol (Beijing)       Date:  2014-02-01

4.  Expression of SLC22A18 regulates oxaliplatin resistance by modulating the ERK pathway in colorectal cancer.

Authors:  Tae Won Kim; Dae Hee Pyo; Eunbyeol Ko; Nak Hyeon Yun; Su Jeong Song; Soo Min Choi; Hye Kyung Hong; Seok-Hyung Kim; Yoon-La Choi; Jeeyun Lee; Woo Yong Lee; Yong Beom Cho
Journal:  Am J Cancer Res       Date:  2022-03-15       Impact factor: 6.166

5.  HES1 Promotes Colorectal Cancer Cell Resistance To 5-Fu by Inducing Of EMT and ABC Transporter Proteins.

Authors:  Lei Sun; Jia Ke; Zhen He; Zexian Chen; Qinghua Huang; Wenjia Ai; Guoqiang Wang; Yisheng Wei; Xiangcai Zou; Shi Zhang; Ping Lan; Chuyuan Hong
Journal:  J Cancer       Date:  2017-08-23       Impact factor: 4.207

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.